Fingolimod Treatment in Relapsing-Remitting Multiple Sclerosis Patients: A Prospective Observational Multicenter Postmarketing Study

Figure 4

Kaplan-Meyer plot of cumulative proportion of patients remaining free from new or newly enlarging T2 lesions over time from start of fingolimod therapy.